EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Assessing the Use of Medical Insurance Claims and Electronic Health Records to Measure COVID-19 Vaccination During Pregnancy

Matthew M Coates, Stacey L Rowe, Sheena G Sullivan, Flor M Munoz, Onyebuchi A Arah, Annette K Regan

Drug Safety · 2026

DOI: 10.1007/s40264-025-01641-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Safety, 2026. Verfasst von Matthew M Coates und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA), Los Angeles, CA, USA. mmcoates@ucla.edu. Hauptthemen laut MEDLINE: Electronic Health Records, COVID-19 Vaccines, COVID-19, Vaccination. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: The safety and effectiveness of COVID-19 vaccination during pregnancy are commonly assessed using administrative health records, which may misclassify vaccine exposures. OBJECTIVE: The aim of this study was to compare the capture of COVID-19 vaccines in commercial insurance claims records and electronic health records (EHR) before and during pregnancy in a cohort in the United States and demonstrate the implications of observed misclassification on vaccine safety and effectiveness estimates. METHODS: Analysis of de-identified data from the Optum Labs Data Warehouse (OLDW) included pregnancies ending after December 11, 2020, and beginning before January 1, 2023, among people aged 15-54 years who were continuously enrolled in health insurance and had EHR data available. We compared the capture of COVID-19 vaccines from insurance claims and EHR databases to the combined and deduplicated doses using clinical procedure and drug codes, assessing records over time and by gestational age, dose number, vaccine manufacturer, and socioeconomic variables. RESULTS: For 29,663 eligible pregnancies, we identified 25,124 COVID-19 vaccine doses (87% in claims and 35% in EHR). About 44% had received one or more doses of a COVID-19 vaccine before or during pregnancy in the combined data, compared with 41% in the insurance claims data and 16% in the EHR data. Records of vaccination relative to the combined data improved in the claims data and declined in the EHR data over time. Vaccine manufacturer information from records without procedure codes in EHR data was unreliable, and a greater proportion of combined doses were recorded in EHR when the cohort was restricted to people with more frequent EHR encounters. The magnitudes of exposure misclassification observed, particularly in EHR data, could substantially bias estimates of vaccine effectiveness and safety. CONCLUSIONS: Insurance claims data captured a larger proportion of COVID-19 vaccine doses than EHR data, and this proportion increased over time. Combining data from multiple administrative health records sources can improve COVID-19 vaccine measurement before and during pregnancy and may be important to reduce bias in studies of vaccine effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electronic Health RecordsCOVID-19 VaccinesCOVID-19VaccinationInsurance Claim ReviewInsurance, HealthHumansFemalePregnancyAdultAdolescentUnited StatesYoung AdultMiddle AgedDatabases, FactualCohort Studies

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA), Los Angeles, CA, USA. mmcoates@ucla.edu.
  • Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
  • School of Clinical Sciences, Monash University, Melbourne, Australia.
  • Division of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Cancer Institute

Zitieren

APA

Coates, M. M., Rowe, S. L., Sullivan, S. G., Munoz, F. M., Arah, O. A., & Regan, A. K. (2026). Assessing the Use of Medical Insurance Claims and Electronic Health Records to Measure COVID-19 Vaccination During Pregnancy. Drug Safety. https://doi.org/10.1007/s40264-025-01641-7

Vancouver

Coates MM, Rowe SL, Sullivan SG, Munoz FM, Arah OA, Regan AK. Assessing the Use of Medical Insurance Claims and Electronic Health Records to Measure COVID-19 Vaccination During Pregnancy. Drug Safety. 2026. doi:10.1007/s40264-025-01641-7

BibTeX
@article{Coates2026,
  author = {Coates, Matthew M and Rowe, Stacey L and Sullivan, Sheena G and Munoz, Flor M and Arah, Onyebuchi A and Regan, Annette K},
  title = {Assessing the Use of Medical Insurance Claims and Electronic Health Records to Measure COVID-19 Vaccination During Pregnancy},
  journal = {Drug Safety},
  year = {2026},
  doi = {10.1007/s40264-025-01641-7}
}
Kostenlos starten →